Novartis To Explore Long-Term "Preferential" Partnerships, CEO Says
Executive Summary
Novartis is interested in exploring preferred partnership arrangements with other pharmaceutical companies that stop short of an outright merger.
You may also be interested in...
Novartis Zelmac DTC Ads To Emphasize Relief Of Abdominal Pain, Bloating
Consumer ads for Novartis Zelmac will emphasize relief of abdominal pain and bloating in addition to constipation, VP and General Manager-U.S. Operations Kurt Graves suggested during an R&D meeting in Basel, Switzerland Dec. 6.
Novartis Zelmac DTC Ads To Emphasize Relief Of Abdominal Pain, Bloating
Consumer ads for Novartis Zelmac will emphasize relief of abdominal pain and bloating in addition to constipation, VP and General Manager-U.S. Operations Kurt Graves suggested during an R&D meeting in Basel, Switzerland Dec. 6.
Novartis, Bristol To Share Zelmac; Novartis Opts For Partnership, Not Merger
Novartis' agreement with Bristol Myers-Squibb to co-promote the irritable bowel syndrome treatment Zelmac (tegaserod) accomplishes one objective of the Swiss company's attempts to grow via a merger in the U.S.